政府工作报告为何修改中医药表述?代表委员为您解读

2018-04-10 黄蓓 中国中医

“支持中医药事业传承创新发展。鼓励中西医结合。”这是3月22日新华社播发的《政府工作报告》全文中对中医药工作修改后的表述。相较于此前的“支持中医药事业传承发展”,修改后增加了“创新”和“鼓励中西医结合”两方面内容。修改的原因何在?又将产生怎样的影响?中国中医药报记者邀请多位代表委员进行了解读。

“支持中医药事业传承创新发展。鼓励中西医结合。”这是3月22日新华社播发的《政府工作报告》全文中对中医药工作修改后的表述。相较于此前的“支持中医药事业传承发展”,修改后增加了“创新”和“鼓励中西医结合”两方面内容。修改的原因何在?又将产生怎样的影响?中国中医药报记者邀请多位代表委员进行了解读

“几千年来,中医药哲学内涵是相对守恒的,但是在对疾病认知、处方用药及针灸推拿等技术层面,每天都在进步,可以说创新是中医传承发展的内生动力,只有创新才能更好传承发展。增加‘创新’二字是非常有必要的。”中国工程院院士、中国中医科学院院长、天津中医药大学校长张伯礼代表在审议报告过程中就曾针对这一问题提出修改建议。他告诉记者,十三届全国人大一次会议审议通过的《政府工作报告》共修改了86处,充分吸收了代表委员的意见建议,也更好地反映了人民的心声。

“中医药的传承与创新是不可分割的,中医药自身的发展就是一个不断吸收当代先进技术的过程。”江苏省政协副主席、南京中医药大学校长胡刚委员告诉记者。我们在继承的同时,也应该把现代生命科学和技术融入中医药的科学研究,解决中医药的重大科学问题,进一步提升中医药的服务水平。

“虽然这次修改只是增加了9个字,但是意义十分重大。在强调传统和现代的辩证关系基础上,报告新增加的内容凸显了传承和创新、中医和西医的辩证关系,这将使得发展中医药的内涵更加丰富,也有利于中医药事业更加全面的发展。”上海中医药大学教授蒋健委员告诉记者。

此次修改还将“鼓励中西医结合”写进报告,这与习近平总书记在十九大报告中提到的“坚持中西医并重,传承发展中医药事业”要求相契合,也对新时代中医药工作者提出了新的要求。

“中医药学和现代医学是站在不同角度去观察、认识人体健康和疾病,二者不能互相替代,但可以优势互补。”张伯礼说,“中西医结合发轫于临床,几十年来取得了长足的进步,成为了具有中国特色的临床诊疗体系和学术体系,也是中医药队伍的一个重要方面军,鼓励中西医结合研究有利于中医药的传承创新发展。这在中医药法中已有明确规定。”

中国工程院院士、中国中西医结合学会会长陈香美代表在审议报告时也提出了相关修改意见,并写了建议案。她表示,中西医结合是中国特有的医学体系,要贯彻好中西医并重的卫生健康方针,首先就是要提高对中西医结合的政策支持力度,在国家层面做好中西医结合的发展规划。同时应该加强中西医结合人才队伍建设,完善中西医结合教育体系,促进中西医两方面人才的相互交流和合理流动。还要发挥中西医结合在全科医师培养中的作用。

“看到将‘鼓励中西医结合’写进政府工作报告,我感到十分振奋。”中日友好医院副院长姚树坤委员在接受采访时说。自幼跟随家人学习中医的姚树坤曾经当过乡村医生,后又进入西医院校接受西医系统知识教育,对于中西医结合,他格外有感情。他认为,中西医结合是一种医学模式,而不仅仅是一种方法学。真正的中西医结合要能够做到在理论层面上融汇贯通,在实践层面上优势互用。鼓励中西医结合,对于健康中国建设具有非常大的促进作用。

“无论中医还是西医,都是着眼于疗效。中医和西医各有优势,可以取长补短,针对不同疾病和同一疾病的不同阶段,选择更优化的治疗方案,应该鼓励中西医结合。”蒋健说。

张伯礼表示,随着中西医结合基础、临床研究的不断深化,中西医结合医学学科体系已逐步完善,但在毕业生专业出口、执业岗位等问题上,一些体制机制的瓶颈尚有待进一步完善。“正因为如此,报告中关于‘鼓励中西医结合’的修改显得尤为重要。”

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2068384, encodeId=1d89206838403, content=<a href='/topic/show?id=91232539890' target=_blank style='color:#2F92EE;'>#代表委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25398, encryptionId=91232539890, topicName=代表委员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Tue May 01 01:10:00 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046491, encodeId=1edf204649139, content=<a href='/topic/show?id=e5d74e881ff' target=_blank style='color:#2F92EE;'>#工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47881, encryptionId=e5d74e881ff, topicName=工作报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Fri Sep 14 07:10:00 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305693, encodeId=0085305693d1, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sat Apr 14 10:47:51 CST 2018, time=2018-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409467, encodeId=7e9c140946e45, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Apr 12 07:10:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449926, encodeId=46a31449926d3, content=<a href='/topic/show?id=bf3e5e46080' target=_blank style='color:#2F92EE;'>#政府工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57460, encryptionId=bf3e5e46080, topicName=政府工作报告)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b15523194, createdName=minlingfeng, createdTime=Thu Apr 12 07:10:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304506, encodeId=275130450625, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue Apr 10 16:19:42 CST 2018, time=2018-04-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2068384, encodeId=1d89206838403, content=<a href='/topic/show?id=91232539890' target=_blank style='color:#2F92EE;'>#代表委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25398, encryptionId=91232539890, topicName=代表委员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Tue May 01 01:10:00 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046491, encodeId=1edf204649139, content=<a href='/topic/show?id=e5d74e881ff' target=_blank style='color:#2F92EE;'>#工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47881, encryptionId=e5d74e881ff, topicName=工作报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Fri Sep 14 07:10:00 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305693, encodeId=0085305693d1, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sat Apr 14 10:47:51 CST 2018, time=2018-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409467, encodeId=7e9c140946e45, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Apr 12 07:10:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449926, encodeId=46a31449926d3, content=<a href='/topic/show?id=bf3e5e46080' target=_blank style='color:#2F92EE;'>#政府工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57460, encryptionId=bf3e5e46080, topicName=政府工作报告)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b15523194, createdName=minlingfeng, createdTime=Thu Apr 12 07:10:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304506, encodeId=275130450625, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue Apr 10 16:19:42 CST 2018, time=2018-04-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2068384, encodeId=1d89206838403, content=<a href='/topic/show?id=91232539890' target=_blank style='color:#2F92EE;'>#代表委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25398, encryptionId=91232539890, topicName=代表委员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Tue May 01 01:10:00 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046491, encodeId=1edf204649139, content=<a href='/topic/show?id=e5d74e881ff' target=_blank style='color:#2F92EE;'>#工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47881, encryptionId=e5d74e881ff, topicName=工作报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Fri Sep 14 07:10:00 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305693, encodeId=0085305693d1, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sat Apr 14 10:47:51 CST 2018, time=2018-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409467, encodeId=7e9c140946e45, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Apr 12 07:10:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449926, encodeId=46a31449926d3, content=<a href='/topic/show?id=bf3e5e46080' target=_blank style='color:#2F92EE;'>#政府工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57460, encryptionId=bf3e5e46080, topicName=政府工作报告)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b15523194, createdName=minlingfeng, createdTime=Thu Apr 12 07:10:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304506, encodeId=275130450625, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue Apr 10 16:19:42 CST 2018, time=2018-04-10, status=1, ipAttribution=)]
    2018-04-14 大爰

    学习了谢谢分享!!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2068384, encodeId=1d89206838403, content=<a href='/topic/show?id=91232539890' target=_blank style='color:#2F92EE;'>#代表委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25398, encryptionId=91232539890, topicName=代表委员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Tue May 01 01:10:00 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046491, encodeId=1edf204649139, content=<a href='/topic/show?id=e5d74e881ff' target=_blank style='color:#2F92EE;'>#工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47881, encryptionId=e5d74e881ff, topicName=工作报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Fri Sep 14 07:10:00 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305693, encodeId=0085305693d1, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sat Apr 14 10:47:51 CST 2018, time=2018-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409467, encodeId=7e9c140946e45, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Apr 12 07:10:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449926, encodeId=46a31449926d3, content=<a href='/topic/show?id=bf3e5e46080' target=_blank style='color:#2F92EE;'>#政府工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57460, encryptionId=bf3e5e46080, topicName=政府工作报告)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b15523194, createdName=minlingfeng, createdTime=Thu Apr 12 07:10:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304506, encodeId=275130450625, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue Apr 10 16:19:42 CST 2018, time=2018-04-10, status=1, ipAttribution=)]
    2018-04-12 cathymary
  5. [GetPortalCommentsPageByObjectIdResponse(id=2068384, encodeId=1d89206838403, content=<a href='/topic/show?id=91232539890' target=_blank style='color:#2F92EE;'>#代表委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25398, encryptionId=91232539890, topicName=代表委员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Tue May 01 01:10:00 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046491, encodeId=1edf204649139, content=<a href='/topic/show?id=e5d74e881ff' target=_blank style='color:#2F92EE;'>#工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47881, encryptionId=e5d74e881ff, topicName=工作报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Fri Sep 14 07:10:00 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305693, encodeId=0085305693d1, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sat Apr 14 10:47:51 CST 2018, time=2018-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409467, encodeId=7e9c140946e45, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Apr 12 07:10:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449926, encodeId=46a31449926d3, content=<a href='/topic/show?id=bf3e5e46080' target=_blank style='color:#2F92EE;'>#政府工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57460, encryptionId=bf3e5e46080, topicName=政府工作报告)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b15523194, createdName=minlingfeng, createdTime=Thu Apr 12 07:10:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304506, encodeId=275130450625, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue Apr 10 16:19:42 CST 2018, time=2018-04-10, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2068384, encodeId=1d89206838403, content=<a href='/topic/show?id=91232539890' target=_blank style='color:#2F92EE;'>#代表委员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25398, encryptionId=91232539890, topicName=代表委员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Tue May 01 01:10:00 CST 2018, time=2018-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2046491, encodeId=1edf204649139, content=<a href='/topic/show?id=e5d74e881ff' target=_blank style='color:#2F92EE;'>#工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47881, encryptionId=e5d74e881ff, topicName=工作报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Fri Sep 14 07:10:00 CST 2018, time=2018-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305693, encodeId=0085305693d1, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sat Apr 14 10:47:51 CST 2018, time=2018-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409467, encodeId=7e9c140946e45, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Apr 12 07:10:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449926, encodeId=46a31449926d3, content=<a href='/topic/show?id=bf3e5e46080' target=_blank style='color:#2F92EE;'>#政府工作报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57460, encryptionId=bf3e5e46080, topicName=政府工作报告)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4b15523194, createdName=minlingfeng, createdTime=Thu Apr 12 07:10:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304506, encodeId=275130450625, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue Apr 10 16:19:42 CST 2018, time=2018-04-10, status=1, ipAttribution=)]
    2018-04-10 大爰

    学习了谢谢分享!!

    0

相关资讯

李克强作政府工作报告(全文)

各位代表:现在,我代表国务院,向大会报告过去五年政府工作,对今年工作提出建议,请予审议,并请全国政协委员提出意见。

直击总理政府工作报告 分级诊疗和医联体建设加快推进

3月5日上午9时,十三届全国人大一次会议在人民大会堂开幕,听取国务院总理李克强关于政府工作的报告,审查国务院关于2017年国民经济和社会发展计划执行情况与2018年国民经济和社会发展计划草案的报告,审查国务院关于2017年中央和地方预算执行情况与2018年中央和地方预算草案的报告,听取全国人大常委会关于宪法修正案草案的说明。

李克强:扩大医疗、养老、教育等领域开放

国务院总理李克强5日在作政府工作报告时说,推动形成全面开放新格局。进一步拓展开放范围和层次,完善开放结构布局和体制机制,以高水平开放推动高质量发展。